Canada markets close in 1 hour 37 minutes

Creo Medical Group PLC (1RC.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.39400.0000 (0.00%)
As of 04:08PM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 152.03M
Enterprise Value 131.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.66
Price/Book (mrq)1.77
Enterprise Value/Revenue 4.50
Enterprise Value/EBITDA -5.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 344.85%
S&P500 52-Week Change 324.19%
52 Week High 30.5350
52 Week Low 30.2580
50-Day Moving Average 30.3844
200-Day Moving Average 30.3866

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5361.48M
Implied Shares Outstanding 6385.87M
Float 8232.24M
% Held by Insiders 120.68%
% Held by Institutions 142.85%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin -85.54%
Operating Margin (ttm)-85.35%

Management Effectiveness

Return on Assets (ttm)-19.98%
Return on Equity (ttm)-38.49%

Income Statement

Revenue (ttm)29.27M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)N/A
EBITDA -25.7M
Net Income Avi to Common (ttm)-25.04M
Diluted EPS (ttm)-0.1300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.5M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)9.2M
Total Debt/Equity (mrq)13.33%
Current Ratio (mrq)4.13
Book Value Per Share (mrq)0.26

Cash Flow Statement

Operating Cash Flow (ttm)-23.55M
Levered Free Cash Flow (ttm)-20.51M